Johnson & Johnson single-dose COVID-19 vaccine: Pharma giant requests study on 12-to-17-year-olds in India

0 26

Johnson and Johnson has written a letter to Central Drugs Standard Control Organisation (CDSCO) requesting the study of single shot COVID-19 vaccine on individuals between 12 and 17 years of age in India.

Leave A Reply

Your email address will not be published.